Skip to main content
Clinical Trials/NCT04245579
NCT04245579
Completed
Not Applicable

Cognitive Training in Elders Without Dementia Using UMAM Method. Genetic, Brain Volume and Cognitive Reserve Predictors: A Randomized Controlled Study

Madrid Salud1 site in 1 country199 target enrollmentOctober 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Age-Related Memory Disorders
Sponsor
Madrid Salud
Enrollment
199
Locations
1
Primary Endpoint
Change in visual memory
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The study is oriented to analyze the effectiveness of a cognitive training method (UMAM) on cognitive functions, subjective memory and mood state in elderly people without dementia. On the other hand, the study aims to examine whether variables such as cognitive reserve (e.g. educational level), APOE genotype and intracranial volume are related to increased benefit after the intervention. The researchers hope to find that greater cognitive reserve, not having the APOE allele ε4, and a greater volume of memory-related brain areas, are associated with better outcomes after the cognitive intervention.

Registry
clinicaltrials.gov
Start Date
October 2013
End Date
May 2015
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Madrid Salud
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Being over 60 years old.
  • Having a global cognitive performance \> 23 in the Mini Mental State Examination Test.
  • Having no history of neurological or serious psychiatric disorders (severe psycho-affective disorders and psychosis or other psychiatric disorders like alcoholism).

Exclusion Criteria

  • Chronic use of anxiolytics.
  • Chronic use of neuroleptics.
  • Chronic use of anticonvulsants.
  • Having hearing or vision impairments that would preclude testing.
  • Magnetic Resonance Imaging (MRI) contraindications.

Outcomes

Primary Outcomes

Change in visual memory

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in visual memory, assessed with the Rey memory test (form B). The score ranges from 0 to 22 points. Higher scores indicate a better outcome.

Change in general cognition

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in general cognition, assessed with the Mini Mental State Examination Test (MMSE) and the 7 Minutes Test (7M).The score ranges from 0 to 30 points (MMSE) and from 0 to 89 points (7M). In both cases, the higher scores indicate a better outcome.

Change in attentional amplitude

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in attentional amplitude, assessed with the Direct Digit Test of the Wechsler Memory Scale-III. The score ranges from 0 to 16 points. Higher scores indicate a better outcome.

Change in verbal fluency (language)

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in phonologic and semantic verbal fluency, assessed with the Phonological Verbal Fluency Test and the Semantic Fluency Test respectively. The score goes from zero onwards (there is no upper limit). Higher scores indicate a better outcome.

Change in mood

Time Frame: This variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in mood, assessed with the Geriatric Depression Scale. The score ranges from 0 to 15 points. Higher scores indicate a worse outcome.

The Brain Volume as a predictor of change.

Time Frame: The Brain Volume was assessed in the pre-intervention assessment.

The Brain Volume (total gray volume, left hippocampus, right hippocampus and total intracranial volume) was assessed by magnetic resonance imaging. Unit of measure: mm3.

Change in daily memory

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in daily memory, assessed with the Rivermead Behavioral Memory Test. The score ranges from 0 to 24 points. Higher scores indicate a better outcome.

The Cognitive Reserve as a predictor of change.

Time Frame: Cognitive Reserve was assessed in the pre-intervention assessment.

The Cognitive Reserve was assessed with Rami Test. The score ranges from 0 to 25 points.

Change in verbal memory

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in verbal memory, assessed with the Word List Test of the Wechsler Memory Scale-III. The score ranges from 0 to 48 points. Higher scores indicate a better outcome.

Change in logical memory

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in immediate and delayed logical memory, assessed with the Logical Memory Test (immediate and delayed units) of the Wechsler Memory Scale-III. The score ranges from 0 to 75 points (immediate units) and from 0 to 50 (delayed units). Higher scores indicate a better outcome.

Change in attentional control

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in attentional control, assessed with the Inverse Digit Test of the Wechsler Memory Scale-III. The score ranges from 0 to 14 points. Higher scores indicate a better outcome.

Change in attention and processing speed

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in attention, assessed with the Trail Making Test, form A. The score ranges from 0 to 200 points. Higher scores indicate a worse outcome.

Change in subjective memory

Time Frame: This variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in Subjective Memory, assessed with the Memory Failures of Everyday Questionnaire.The score ranges from 0 to 56 points. Higher scores indicate a worse outcome.

The Genetic Profile as a predictor of change.

Time Frame: The Genetic Profile was assessed in the pre-intervention assessment.

The Genetic Profile was obtained by genetic analysis employing a blood test. APOE gene has been coded as 1 (meaning no ε4 allele), or 0 (for at least one ε4 allele).

Change in alternating attention and planning

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in alternating attention and planning, assessed with the Trail Making Test, form B. The score ranges from 0 to 400 points. Higher scores indicate a worse outcome.

Change in naming ability (language)

Time Frame: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

The measure of the post-intervention change in naming ability, assessed with the Boston Naming Test. The score ranges from 0 to 60 points. Higher scores indicate a better outcome.

Study Sites (1)

Loading locations...

Similar Trials